Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Measles | 3 | 2019 | 608 | 0.86 | Why? |
Rubella | 2 | 2019 | 127 | 0.82 | Why? |
Malaria Vaccines | 2 | 2017 | 90 | 0.77 | Why? |
Encephalitis, Japanese | 1 | 2019 | 58 | 0.73 | Why? |
Mumps | 1 | 2017 | 110 | 0.60 | Why? |
Immunosenescence | 1 | 2016 | 169 | 0.54 | Why? |
Vaccination | 12 | 2021 | 19050 | 0.51 | Why? |
Sex Characteristics | 3 | 2020 | 1120 | 0.51 | Why? |
Antibody Formation | 3 | 2021 | 4038 | 0.43 | Why? |
Health Services for the Aged | 1 | 2016 | 602 | 0.38 | Why? |
Microbiota | 1 | 2017 | 1240 | 0.33 | Why? |
Malaria | 1 | 2017 | 1097 | 0.33 | Why? |
Immunity | 1 | 2017 | 2651 | 0.30 | Why? |
Vaccines | 3 | 2020 | 3692 | 0.27 | Why? |
Health Promotion | 1 | 2017 | 2020 | 0.26 | Why? |
Health Status | 1 | 2017 | 3259 | 0.26 | Why? |
Disease Susceptibility | 1 | 2016 | 4002 | 0.25 | Why? |
Communicable Diseases | 1 | 2016 | 2148 | 0.22 | Why? |
Aging | 1 | 2017 | 3581 | 0.22 | Why? |
Whooping Cough | 2 | 2019 | 201 | 0.20 | Why? |
HLA-A2 Antigen | 1 | 2020 | 134 | 0.20 | Why? |
BCG Vaccine | 3 | 2019 | 1137 | 0.20 | Why? |
Rubella Vaccine | 1 | 2019 | 17 | 0.20 | Why? |
Antigens, Heterophile | 1 | 2018 | 5 | 0.19 | Why? |
Viral Vaccines | 1 | 2020 | 7560 | 0.19 | Why? |
Bordetella pertussis | 1 | 2019 | 117 | 0.18 | Why? |
Pertussis Vaccine | 1 | 2019 | 89 | 0.18 | Why? |
Prebiotics | 1 | 2017 | 53 | 0.17 | Why? |
Vaccines, Conjugate | 1 | 2019 | 328 | 0.16 | Why? |
Antibodies, Protozoan | 1 | 2017 | 121 | 0.16 | Why? |
Immunity, Heterologous | 1 | 2017 | 129 | 0.16 | Why? |
T-Lymphocytes, Cytotoxic | 1 | 2020 | 552 | 0.16 | Why? |
Vitamin A | 1 | 2017 | 188 | 0.16 | Why? |
Immunodominant Epitopes | 1 | 2021 | 813 | 0.15 | Why? |
Sex Factors | 3 | 2018 | 11014 | 0.15 | Why? |
Immunity, Innate | 3 | 2020 | 6570 | 0.15 | Why? |
Measles Vaccine | 1 | 2019 | 301 | 0.15 | Why? |
Gonadal Steroid Hormones | 1 | 2018 | 328 | 0.15 | Why? |
CD8-Positive T-Lymphocytes | 3 | 2021 | 5837 | 0.15 | Why? |
Toll-Like Receptors | 1 | 2018 | 365 | 0.14 | Why? |
Receptors, Antigen, T-Cell | 1 | 2021 | 760 | 0.14 | Why? |
Antibodies, Viral | 3 | 2021 | 51949 | 0.13 | Why? |
Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.13 | Why? |
Plasmodium falciparum | 1 | 2017 | 337 | 0.13 | Why? |
Global Health | 1 | 2016 | 13911 | 0.12 | Why? |
Cytokines | 3 | 2020 | 15010 | 0.12 | Why? |
Malaria, Falciparum | 1 | 2017 | 377 | 0.12 | Why? |
Epigenesis, Genetic | 1 | 2017 | 711 | 0.11 | Why? |
Mass Vaccination | 1 | 2021 | 1101 | 0.10 | Why? |
T-Lymphocytes | 2 | 2018 | 6670 | 0.10 | Why? |
Genetic Vectors | 1 | 2017 | 1600 | 0.10 | Why? |
Infant | 5 | 2019 | 30274 | 0.10 | Why? |
Adaptive Immunity | 2 | 2021 | 2585 | 0.09 | Why? |
Netherlands | 1 | 2017 | 3533 | 0.09 | Why? |
Autoimmune Diseases | 1 | 2021 | 1996 | 0.09 | Why? |
Nutritional Status | 1 | 2017 | 1403 | 0.08 | Why? |
Communicable Disease Control | 1 | 2016 | 29620 | 0.08 | Why? |
Diet | 1 | 2019 | 2052 | 0.08 | Why? |
Humans | 22 | 2021 | 930598 | 0.08 | Why? |
Life Style | 1 | 2019 | 2708 | 0.08 | Why? |
Dietary Supplements | 1 | 2017 | 2251 | 0.07 | Why? |
Psoriasis | 1 | 2019 | 1739 | 0.07 | Why? |
Saliva | 1 | 2020 | 4679 | 0.07 | Why? |
World Health Organization | 1 | 2016 | 4213 | 0.06 | Why? |
CD4-Positive T-Lymphocytes | 3 | 2021 | 4545 | 0.06 | Why? |
Pandemics | 6 | 2021 | 389249 | 0.05 | Why? |
Vaccines, Acellular | 1 | 2019 | 12 | 0.05 | Why? |
Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.05 | Why? |
Aged | 5 | 2021 | 215776 | 0.05 | Why? |
Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
Haemophilus influenzae type b | 1 | 2019 | 30 | 0.05 | Why? |
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 203 | 0.05 | Why? |
Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
Child | 5 | 2021 | 70012 | 0.05 | Why? |
Epitopes, T-Lymphocyte | 2 | 2021 | 2262 | 0.05 | Why? |
Female | 10 | 2021 | 380317 | 0.05 | Why? |
Haemophilus Vaccines | 1 | 2019 | 76 | 0.05 | Why? |
Poliovirus Vaccine, Inactivated | 1 | 2019 | 72 | 0.05 | Why? |
Amino Acid Motifs | 1 | 2021 | 620 | 0.05 | Why? |
Immunoglobulin A | 2 | 2021 | 3567 | 0.05 | Why? |
Tetanus | 1 | 2019 | 61 | 0.05 | Why? |
Male | 9 | 2021 | 367725 | 0.05 | Why? |
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2019 | 92 | 0.05 | Why? |
Diphtheria | 1 | 2019 | 74 | 0.05 | Why? |
Autoantigens | 1 | 2021 | 388 | 0.05 | Why? |
Phytohemagglutinins | 1 | 2017 | 15 | 0.05 | Why? |
Chemokine CCL4 | 1 | 2018 | 71 | 0.04 | Why? |
Chemokine CCL3 | 1 | 2018 | 103 | 0.04 | Why? |
Immunologic Memory | 2 | 2020 | 3362 | 0.04 | Why? |
Adult | 6 | 2021 | 244371 | 0.04 | Why? |
Polyproteins | 1 | 2020 | 814 | 0.04 | Why? |
Australia | 2 | 2021 | 6306 | 0.04 | Why? |
Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
Receptors, IgG | 1 | 2021 | 578 | 0.04 | Why? |
Toll-Like Receptor 2 | 1 | 2018 | 198 | 0.04 | Why? |
Tetanus Toxoid | 1 | 2017 | 136 | 0.04 | Why? |
Cicatrix | 1 | 2017 | 129 | 0.04 | Why? |
Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
Financing, Government | 1 | 2021 | 434 | 0.04 | Why? |
Chemokine CCL2 | 1 | 2018 | 389 | 0.04 | Why? |
Africa, Western | 1 | 2017 | 363 | 0.04 | Why? |
Immunophenotyping | 1 | 2020 | 1290 | 0.04 | Why? |
Antibodies, Bacterial | 1 | 2019 | 510 | 0.04 | Why? |
Immunoglobulin Isotypes | 1 | 2017 | 308 | 0.04 | Why? |
Autoimmunity | 1 | 2021 | 841 | 0.03 | Why? |
Pneumococcal Vaccines | 1 | 2019 | 571 | 0.03 | Why? |
Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.03 | Why? |
Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
Ligands | 1 | 2018 | 1300 | 0.03 | Why? |
Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
Middle Aged | 5 | 2021 | 270681 | 0.03 | Why? |
China | 1 | 2019 | 50654 | 0.03 | Why? |
Child, Preschool | 3 | 2021 | 36283 | 0.03 | Why? |
Interleukin-10 | 1 | 2018 | 1409 | 0.03 | Why? |
Leukocytes, Mononuclear | 1 | 2020 | 2115 | 0.03 | Why? |
Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
Lupus Erythematosus, Systemic | 1 | 2021 | 1380 | 0.03 | Why? |
Autoantibodies | 1 | 2021 | 2094 | 0.03 | Why? |
Immunization | 1 | 2019 | 2019 | 0.02 | Why? |
Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
Convalescence | 1 | 2021 | 2829 | 0.02 | Why? |
Peptide Fragments | 1 | 2020 | 2075 | 0.02 | Why? |
Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
Monocytes | 1 | 2020 | 2978 | 0.02 | Why? |
Immune System | 1 | 2017 | 1479 | 0.02 | Why? |
Arthritis, Rheumatoid | 1 | 2021 | 2043 | 0.02 | Why? |
International Cooperation | 1 | 2021 | 3436 | 0.02 | Why? |
Parents | 1 | 2020 | 2758 | 0.02 | Why? |
Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
Immunity, Cellular | 1 | 2017 | 3614 | 0.02 | Why? |
Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
Immunity, Humoral | 1 | 2017 | 4849 | 0.01 | Why? |
Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
Interleukin-6 | 1 | 2018 | 7522 | 0.01 | Why? |
Exercise | 1 | 2019 | 6771 | 0.01 | Why? |
Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
Severity of Illness Index | 1 | 2019 | 48226 | 0.01 | Why? |
Flanagan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(145)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_